















Approximately	 50%	of	 ankle	 fractures	 require	 internal	 fixation.	 A	 tourniquet	 is	 often	








.470).	 Sensitivity	 analyses	 (unadjusted	 intention‐to‐treat	 analysis	 and	 as‐treated	
analysis)	gave	similar	non‐significant	results.	The	covariate‐adjusted	mean	difference	in	
duration	of	 operation	was	3.03	minutes	 (95%	CI	 –4.96,	11.02;	p	 =	 .455),	 favoring	 the	
tourniquet	group;	sensitivity	analyses	again	gave	similar	results.	Adverse	events	did	not	
differ	significantly	between	groups.	In	conclusion,	the	use	of	a	tourniquet	during	internal	












and	 occuring	 at	 a	 rate	 of	 187/100,000	 people	 each	 year	 [1].	 This	 equates	 to	 roughly	
121,000	 ankle	 fractures	 in	 the	 UK	 each	 year.	 Approximately	 half	 are	 deemed	 to	 be	
unstable	 and	 subsequently	 require	 operative	 fixation.	 Operative	 management	 is	







evidenced	 by	 a	 longer	 hospital	 stay,	 as	 previously	 reported	 [6,7].	 Accordingly,	 the	








Patients	were	 recruited	 from	 the	University	Hospital	of	North	Midlands	 (UHNM)	NHS	





(rather	 than	conservative	 treatment)	was	 indicated.	Exclusions	 included	patients	with	
open	 fractures,	 pilon	 fractures,	 previously	 malunited	 fractures,	 peripheral	 vascular	
disease	 precluding	 tourniquet	 use,	 and	 patients	 with	 bilateral	 fractures	 or	 multiple	
injuries.	 Patients	who	were	 not	 ambulatory	 prior	 to	 the	 fracture,	 unable	 to	 complete	
questionnaires,	or	with	a	language	barrier	that	could	not	be	overcome	through	hospital	
translation	services	were	also	excluded.		





in	 a	 1:1	 ratio	 using	 an	 online	 third‐party	 computerized	 randomization	 service	 at	 the	
University	of	York.	Randomization	was	stratified	by	age	(18–50,	over	50),	using	randomly	
permuted	blocks	of	4	and	6.		
Fracture	 type	was	 classified	according	 to	 the	Weber	 classification	 [8].	Weber	grade	A	
indicates	a	fracture	below	the	talar	dome,	grade	B	denotes	a	fracture	of	the	distal	fibula	
at	the	level	of	the	tibiofibular	syndesmosis,	and	grade	C	indicates	a	fracture	of	the	distal	












supine	 with	 a	 sandbag	 under	 the	 buttock	 of	 the	 affected	 side.	 For	 those	 patients	
randomized	 to	 have	 a	 tourniquet,	 this	 was	 applied	 above	 the	 knee	 and	 the	 leg	 was	
prepared,	 draped	 and	 elevated	 before	 tourniquet	 inflation.	 For	 all	 patients,	 fibular	
fixation	was	by	plate	and	screws	via	a	lateral	incision,	following	reduction	of	the	fracture;	








immediate	 post‐operative	 complications	 were	 collected	 or	 verified	 from	 patients’	
records.	Authors	HM	and	DM	were	among	the	participating	surgeons.	
Blinding	
Operating	 staff	were	necessarily	 aware	 of	whether	 or	 not	 a	 tourniquet	was	used,	 but	
patients	were	 not	 told	 until	 after	 the	 study.	 For	 determination	 of	 LOS,	 patients	were	























with	 a	 predetermined	 statistical	 analysis	 plan.	 The	 assumptions	 of	 statistical	 models	
were	 checked	 prior	 to	 analysis.	 As	 the	 distribution	 of	 residuals	 did	 not	 meet	 the	
assumptions	 of	 linear	 regression,	 LOS	 was	 compared	 between	 groups	 using	 Poisson	
regression,	adjusting	for	Weber	classification,	ASA	grade,	sex,	BMI,	treatment	center,	and	
time	from	fracture	to	surgery,	and	including	the	stratification	factor	(age)	in	the	model;	



















Between	 August	 2012	 and	 August	 2015,	 a	 total	 of	 471	 patients	 were	 screened	 for	














treated).	The	 treatment	 effect	 shown	 is	 the	antilogged	coefficient	 from	 the	 regression	




In	 the	 primary	 ITT	 analysis,	 there	 was	 a	 very	 small	 and	 statistically	 non‐significant	




as‐treated	 sensitivity	 analysis,	 the	difference	was	 again	 small	 and	non‐significant,	 but	
favored	the	tourniquet	group:	LOS	was	on	average	3.8%	shorter	than	in	the	no‐tourniquet	
group.		
Figure	3	shows	mean	differences	 in	LOS	 from	the	adjusted	 ITT	analysis	by	subgroups	
defined	by	sex,	age	(18–50,	over	50),	Weber	classification	(B,	C)	and	ASA	grade	(1,	2,	3).	
The	estimates	 for	 the	Weber	classification	subgroups	were	very	similar	 to	 the	overall	
estimate.	Estimates	 for	male	patients	and	 those	over	50	appeared	 to	 favor	non‐use	of	















variables,	 in	 addition	 to	 tourniquet	 use,	were	 entered	 in	 a	 Poisson	 regression	model,	
following	 a	 check	 for	 collinearity:	 age,	 BMI,	 time	 from	 fracture	 to	 surgery,	 time	 to	








predicts	 longer	 LOS)	 were	 significant	 independent	 predictors.	 Ignoring	 statistical	
significance,	BMI,	age	and	duration	of	operation	were	additionally	stronger	predictors	
than	 tourniquet	 use.	 It	 should	 be	 noted	 that	 no	 sample	 size	 calculation	 had	 been	
performed	for	these	unplanned	analyses.	
Adverse	events	
Seven	 patients	 experienced	 intraoperative	 complications	 (Table	 4);	 2	 (2.2%)	 in	 the	
tourniquet	group	and	5	(5.4%)	in	the	no‐tourniquet	group	(odds	ratio	with	no	tourniquet	
as	 reference	 category	0.396	 (95%	CI	0.075,	 2.093);	p	=	 .444,	 Fisher’s	 exact	 test).	One	
patient	experienced	severe	pain	postoperatively,	when	a	cast	was	applied	(an	alternative	




readmitted	 for	 further	 surgery	 on	 the	 affected	 ankle.	 There	was	 one	 serious	 adverse	
event.	A	patient	in	the	no‐tourniquet	group	required	prolonged	hospitalization	following	




The	 non‐use	 of	 a	 tourniquet	 did	 not	 produce	 a	 statistically	 significant	 or	 clinically	
important	difference	in	the	primary	outcome	measure,	and	this	study	did	not	therefore	
confirm	previous	evidence	that	use	of	a	tourniquet	increases	length	of	stay	[5–7].	In	the	






















was	 used	 for	 19	 patients)	 than	 in	 the	 tourniquet	 group	 (only	 3	 patients	 had	 no	
tourniquet).	This	may	reflect	the	surgeon’s	personal	preference	for	use	of	a	tourniquet	to	
provide	a	bloodless	field.	The	as‐treated	analysis,	which	reflects	this	protocol	deviation,	
showed	 LOS	 to	 be	 slightly	 shorter	 with	 tourniquet	 use,	 but	 the	 difference	 is	 non‐





blinded,	 allowing	 us	 to	 reach	 unbiased	 conclusions	 regarding	 LOS.	 All	 staff	 assessing	
patients’	fitness	for	discharge	were	blinded	to	tourniquet	use,	reducing	the	risk	of	bias	in	






was	 not	 specifically	 powered,	 they	 must	 be	 interpreted	 with	 caution.	 Similarly,	 the	
subgroup	analyses	were	exploratory	and	should	be	interpreted	accordingly.	The	high	rate	
of	protocol	deviation	in	the	no‐tourniquet	group	suggests,	 in	some	instances,	a	 lack	of	
clinical	 equipoise,	 though	 the	 as‐treated	 analysis	 indicates	 this	 is	 unlikely	 to	 have	
seriously	biased	the	statistical	comparisons.	
In	 conclusion,	 our	 study	 has	 demonstrated	 that	 hospital	 LOS	 following	 operative	
management	 of	 closed	 ankle	 fractures	 in	 skeletally	mature	 adults	 is	 not	 significantly	
affected	by	the	use	of	a	tourniquet	during	surgery.	Pre‐injury	medical	condition	of	the	
patient	 appeared	 to	 be	 the	 single	 most	 influential	 factor	 identified	 affecting	 hospital	









Sex;	n	(%)		 male	 41	(44)	 35	(37)	
female	 53	(56)	 59	(63)	
















































Primary:	 	 	 	 	 	
ITT	analysis,	
adjusted	b		 1.74	 1.62	 1.072	 0.854,	1.346	 .549	
Sensitivity:	 	 	 	 	 	
ITT	analysis,	
unadjusted		 1.79	 1.65	 1.084	 0.871,	1.348	 .470	
As‐treated	analysis,	












ASA	grade	 10.571	 2	 .005	
Time	from	fracture	to	surgery	 4.996	 1	 .025	
BMI	 3.024	 1	 .082	
Age	 .879	 1	 .349	
Duration	of	operation	 .826	 1	 .363	
Tourniquet	use	 .806	 1	 .369	
Sex	 .507	 1	 .476	
Weber	classification	 .068	 1	 .795	
Mechanism	of	fracture	 .826	 3	 .843	
Regular	smoker	 .015	 1	 .904	


































reflect	 those	 of	 the	 NHS,	 NIHR,	 or	 the	 Department	 of	 Health	 and	 Social	 Care.	 It	 was	
sponsored	by	University	Hospitals	of	North	Midlands	NHS	Trust.		
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